title: [Inflammatory markers in heart failure].
abstract: Heart failure is a leading cause of cardiovascular mortality and morbidity. It has been shown that inflammatory markers may play a role in the pathogenesis of heart failure. Therefore, inflammatory markers and anticytokine therapy in heart failure have become the attractive subjects in the literature. There are new studies regarding this issue in the literature. In this article, we reviewed inflammatory markers in heart failure and their prognostic significance based on the literature data.
authors.affiliation: GATA Haydarpaşa Eğitim Hastanesi, Kardiyoloji Servisi, Istanbul, Türkiye. drnamikozmen@yahoo.com
authors.forename: Namik
authors.initials: N
authors.lastname: Ozmen
authors.forename: Bekir Sitki
authors.initials: BS
authors.lastname: Cebeci
authors.forename: Ejder
authors.initials: E
authors.lastname: Kardeşoğlu
mesh_terms: D015415:Biomarkers / Q000097:blood; D016207:Cytokines / Q000037:antagonists & inhibitors; D003937:Diagnosis, Differential; D006333:Heart Failure / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D011237:Predictive Value of Tests; D011379:Prognosis; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D015415:Biomarkers; D016207:Cytokines; D014409:Tumor Necrosis Factor-alpha